Catalysts for Center for Biomedical Research for Neurodegenetive Diseases
7 tracked
Nov 10, 2025
approval
METFORMIN HYDROCHLORIDE — FDA approval
Center for Biomedical Research for Neurodegenetive Diseases
→
Feb 22, 2019
approval
METFORMIN HYDROCHLORIDE — FDA approval
Center for Biomedical Research for Neurodegenetive Diseases
→
Aug 14, 2017
approval
METFORMIN HYDROCHLORIDE — FDA approval
Center for Biomedical Research for Neurodegenetive Diseases
→
Aug 14, 2017
approval
METFORMIN HYDROCHLORIDE — FDA approval
Center for Biomedical Research for Neurodegenetive Diseases
→
Apr 5, 2016
approval
METFORMIN HYDROCHLORIDE — FDA approval
Center for Biomedical Research for Neurodegenetive Diseases
→
Jan 26, 2012
approval
METFORMIN HYDROCHLORIDE — FDA approval
Center for Biomedical Research for Neurodegenetive Diseases
→
Apr 22, 2010
approval
METFORMIN HYDROCHLORIDE — FDA approval
Center for Biomedical Research for Neurodegenetive Diseases
→